Although it was once thought that the central nervous system (CNS) of mammals was
incapable of substantial recovery from injury, it is now clear that the adult
CNS remains responsive to various substances that can promote cell survival and
stimulate axonal growth. Among these substances are growth factors, including
the neurotrophins and cytokines, and growth-supportive cells such as Schwann
cells, olfactory ensheathing glia, and stem cells. We review the effects of
these substances on promoting axonal growth after spinal cord injury, placing
particular emphasis on the genetic delivery of nervous system growth factors to
specific sites of injury as a means of promoting axonal growth and, in limited
instances, functional recovery.
RichardsJSGoBKRuttRDLazarusPB.
The national spinal cord injury collaborative
database. In: StoverSLDeLIsaJAWhiteneckGG,
eds. Spinal cord injury: Clinical outcomes from model systems.
Gaithersburg, MD:
Aspen, 1995:
10–20.
2.
GoBKDeVivoMJRichardsJS.
The epidemiology of spinal cord injury. In:
StoverSLDeLIsaJAWhiteneckGG,
eds. Spinal cord injury: Clinical outcomes from model systems.
Gaithersburg, MD:
Aspen, 1995:
21–55.
3.
GrillRMuraiKBleschACellular delivery of neurotrophin-3 promotes corticospinal axonal
growth and partial functional recovery after spinal cord
injury. J Neurosci1997; 17:
5560–72.
4.
DavidSAguayoAJ.
Axonal elongation into peripheral nervous system
“bridges” after central nervous system injury in adult
rats. Science1981; 214:
931–3.
5.
Levi-MontalciniRHamburgerV.
Selective growth stimulating effects of mouse sarcoma on the
sensory and sympathetic nervous system of the chick embryo.
J Exp Zool1951; 116:
321–62.
6.
Levi-MontalciniRHamburgerV.
A diffusible agent of mouse sarcoma, producing hyperplasia of
sympathetic ganglia and hyperneurotization of viscera in the chick
embryo. J Exp Zool1953; 123:
233–88.
7.
CohenSLevi-MontalciniR.
Purification and properties of a nerve growth-promoting
factor isolated from mouse sarcoma. Cancer
Res1957; 17:
15–20.
8.
Levi-MontalciniR.
The nerve growth factor 35 years later.
Science1987; 237:
1154–62.
9.
SchwabME.
Myelin-associated inhibitors of neurite growth and
regeneration in the CNS. Trends Neurosci1990; 13:
452–6.
10.
ThoenenH.
Neurotrophins and neuronal plasticity.
Science1995; 270:
593–8.
11.
TuszynskiMHKordowerJ.
CNS regeneration: Basic science and clinical advances.
San Diego: Academic
Press, 1999.
12.
SniderWD.
Functions of the neurotrophins during nervous system
development: What the knockouts are teaching us.
Cell1994; 77:
627–38.
13.
TessarolloLVogelKSPalkoMEReidSWParadaLF.
Targeted mutation in the neurotrophin-3 gene results in loss
of muscle sensory neurons. Proc Natl Acad Sci U S
A1994; 91:
11844–8.
14.
LiuXErnforsPWuHJaenischR.
Sensory but not motor neuron deficits in mice lacking NT4 and
BDNF. Nature1995; 375:
2–41.
15.
JonesKRFarinasIBackusCReichardtLF.
Targeted disruption of the BDNF gene perturbs brain and
sensory neuron development but not motor neuron development.
Cell1994; 76:
989–99.
16.
FarinasIJonesKRBackusCSevere sensory and sympathetic deficits in mice lacking
neurotrophin-3. Nature1994; 369:
658–61.
17.
CrowleyCSpencerSDNishimuraMCMice lacking nerve growth factor display perinatal loss of
sensory and sympathetic neurons yet develop basal forebrain cholinergic
neurons. Cell1994; 76:
1001–11.
18.
ConoverJCEricksonJTKatzDMNeuronal deficits, not involving motor neurons, in mice lacking
BDNF and/or NT4. Nature1995; 375:
235–8.
19.
HendersonCE.
Role of neurotrophic factors in neuronal
development. Curr Opin Neurobiol1996; 6:
64–70.
20.
SchwartzPMBorghesaniPRLevyRLAbnormal cerebellar development and foliation in BDNF-/- mice
reveals a role for neurotrophins in CNS patterning.
Neuron1997; 19:
269–81.
RosenbergMBFriedmannTRobertsonRCGrafting genetically modified cells to the damaged brain:
Restorative effects of NGF expression.
Science1988; 242:
1575–8.
24.
KoliatsosVENautaHJClatterbuckREMouse nerve growth factor prevents degeneration of axotomized
basal forebrain cholinergic neurons in the monkey. J
Neurosci1990; 10:
3801–13.
25.
TuszynskiMHSangHYoshidaKGageFH.
Recombinant human nerve growth factor infusions prevent
cholinergic neuronal degeneration in the adult primate
brain. Ann Neurol1991; 30:
625–36.
26.
MitsumotoHIkedaKKlinkoszBArrest of motor neuron disease in wobbler mice cotreated with
CNTF and BDNF [see comments). Science1994; 265:
1107–10.
27.
TuszynskiMHMafongEMeyerS.
Central infusions of brain-derived neurotrophic factor and
neurotrophin- 4/5, but not nerve growth factor and neurotrophin-3, prevent
loss of the cholinergic phenotype in injured adult motor
neurons. Neuroscience1996; 71:
761–71.
28.
TuszynskiMHRobertsJSenutMCGene therapy in the adult primate brain: Intraparenchymal grafts
of cells genetically modified to produce nerve growth factor prevent
cholinergic neuronal degeneration. Gene
Ther1996; 3:
305–14.
29.
TuszynskiMHGrillRJBleschA.
Spinal cord regeneration. In: TuszynskiMHKordowerJ,
eds. CNS regeneration: Basic science and clinical advances.
San Diego: Academic
Press, 1999:
605–29.
30.
GageFHFisherLJJinnahHAGrafting genetically modified cells to the brain: Conceptual and
technical issues. Prog Brain Res1990; 82:
1–10.
31.
WhittcmoreSREatonMJOniferSM.
Gene therapy and the use of stem cells for central nervous
system regeneration. Adv Neurol1997; 72:
113–9.
32.
BreakefieldXJacobsAWangS.
Genetic engineering for CNS regeneration. In:
TuszynskiMHKordowerJ,
eds. CNS regeneration: Basic science and clinical advances.
San Diego: Academic
Press, 1999:
251–91.
33.
SuhrSTGageFH.
Gene therapy in the central nervous system: The use of
recombinant retroviruses. Arch Neurol1999; 56:
287–92.
34.
TuszynskiMHPetersonDARayJFibroblasts genetically modified to produce nerve growth factor
induce robust neuritic ingrowth after grafting to the spinal
cord. Exp Neurol1994; 126:
1–14.
35.
NakaharaYGageFHTuszynskiMH.
Grafts of fibroblasts genetically modified to secrete NGF,
BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal
cord. Cell Transplant1996; 5:
191–204.
36.
TuszynskiMHGabrielKGageFHNerve growth factor delivery by gene transfer induces
differential outgrowth of sensory, motor, and noradrenergic neurites after
adult spinal cord injury. Exp Neurol1996; 137:
157–73.
37.
GrillRBleschATuszynskiMH.
Robust growth of chronically injured spinal cord axons
induced by grafts of genetically modified NGF-secreting
cells. Exp Neurol1997; 148:
444–52.
38.
KimDHGutinPHNobleLJTreatment with genetically engineered fibroblasts producing NGF
or BDNF can accelerate recovery from traumatic spinal cord injury in the
adult rat. Neuroreport1996; 7:
2221–5.
39.
TuszynskiMHMuraiKBleschAFunctional characterization of NGF-secreting cell grafts to the
acutely injured spinal cord. Cell
Transplant1997; 6:
361–8.
40.
RamerMSPriestleyJVMcMahonSB.
Functional regeneration of sensory axons into the adult
spinal cord [see comments]. Nature2000; 403:
312–6.
41.
ApfelSCWrightDEWiidemanAMNerve growth factor regulates the expression of brain-derived
neurotrophic factor mRNA in the peripheral nervous system.
Mol Cell Neurosci1996; 7:
134–42.
42.
KobayashiNRFanDPGiehlKMBDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after
cervical axotomy, stimulate GAP-43 and Talphal-tubulin mRNA expression, and
promote axonal regeneration. J Neurosci1997; 17:
9583–95.
43.
LiuYKimDHimesBTTransplants of fibroblasts genetically modified to express BDNF
promote regeneration of adult rat rubrospinal axons and recovery of forelimb
function. J Neurosci1999; 19:
4370–87.
44.
LuPBleschALowKTuszynskiMH.
Cellular delivery of BDNF promotes both motor and sensory
axonal growth after spinal cord injury. Soc Neurosci
Abstr1999; 25: 498.
45.
SchnellLSchneiderRKolbeckRNeurotrophin-3 enhances sprouting of corticospinal tract during
development and after adult spinal cord lesion [see
comments]. Nature1994; 367:
170–3.
46.
BradburyEJKhemaniSVonRNT-3 promotes growth of lesioned adult rat sensory axons
ascending in the dorsal columns of the spinal cord.
Eur J Neurosci1999; 11:
3873–83.
47.
ZhangYDijkhuizenPAAndersonPNNT-3 delivered by an adenoviral vector induces injured dorsal
root axons to regenerate into the spinal cord of adult rats.
J Neurosci Res1998; 54:
554–62.
48.
XuXMGuenardVKleitmanNA combination of BDNF and NT-3 promotes supraspinal axonal
regeneration into Schwann cell grafts in adult rat thoracic spinal
cord. Exp Neurol1995; 134:
261–72.
49.
BleschADiergardtNUyHSTuszynskiMH.
Cellularly delivered NT-4/5 has axonal growth promoting
effects in the injured adult rat spinal cord. Soc
Neurosci Abstr1999; 25: 497.
50.
IkebuchiKWongGGClarkSCInterleukin 6 enhancement of interleukin 3-dependent
proliferation of multipotential hemopoietic progenitors.
Proc Natl Acad Sci U S A1987; 84:
9035–9.
51.
RennickDJacksonJYangGInterleukin-6 interacts with interleukin-4 and other
hematopoietic growth factors to selectively enhance the growth of
megakaryocytic, erythroid, myeloid, and multipotential progenitor
cells. Blood1989; 73:
1828–35.
52.
BazanJF.
Neuropoietic cytokines in the hematopoietic
fold. Neuron1991; 7:
197–208.
53.
BernadAKopfMKulbackiRInterleukin-6 is required in vivo for the regulation of stem
cells and committed progenitors of the hematopoietic system.
Immunity1994; 1:
725–31.
54.
FannMJPattersonPH.
Neuropoietic cytokines and activin A differentially regulate
the phenotype of cultured sympathetic neurons. Proc
Natl Acad Sci U S A1994; 91:
43–7.
55.
MehlerMFMarmurRGrossRCytokines regulate the cellular phenotype of developing neural
lineage species. Int J Dev Neurosci1995; 13:
213–40.
56.
BonniASunYNadal-VicensMRegulation of gliogenesis in the central nervous system by the
JAK-STAT signaling pathway. Science1997; 278:
477–83.
57.
KoblarSATurnleyAMClassonBJNeural precursor differentiation into astrocytes requires
signaling through the leukemia inhibitory factor receptor.
Proc Natl Acad Sci U S A1998; 95:
3178–81.
58.
IpNY.
The neurotrophins and neuropoietic cytokines: Two families of
growth factors acting on neural and hematopoietic cells.
Ann N Y Acad Sci1998; 840:
97–106.
59.
GalliRPaganoSFGrittiAVescoviAL.
Regulation of neuronal differentiation in human CNS stem cell
progeny by leukemia inhibitory factor. Dev
Neurosci2000; 22:
86–95.
60.
ArakawaYSendtnerMThoenenH.
Survival effect of ciliary neurotrophic factor (CNTF) on
chick embryonic motoneurons in culture: Comparison with other neurotrophic
factors and cytokines. J Neurosci1990; 10:
3507–15.
61.
SendtnerMStockliKAThoenenH.
Synthesis and localization of ciliary neurotrophic factor in
the sciatic nerve of the adult rat after lesion and during
regeneration. J Cell Biol1992; 118:
139–48.
62.
MartinouJCMartinouIKatoAC.
Cholinergic differentiation factor (CDF/LIF) promotes
survival of isolated rat embryonic motoneurons in vitro.
Neuron1992; 8:
737–44.
63.
MaedaYMatsumotoMHoriOHypoxia/reoxygenation-mediated induction of astrocyte interleukin
6: A paracrine mechanism potentially enhancing neuron
survival. J Exp Med1994; 180:
2297–308.
64.
KotzbauerPTLampePAEstusSPostnatal development of survival responsiveness in rat
sympathetic neurons to leukemia inhibitory factor and ciliary neurotrophic
factor. Neuron1994; 12:
763–73.
65.
HortonARBarlettPFPennicaDDaviesAM.
Cytokines promote the survival of mouse cranial sensory
neurones at different developmental stages. Eur J
Neurosci1998; 10:
673–9.
66.
ToulmondSVigeXFageDBenavidesJ.
Local infusion of interleukin-6 attenuates the neurotoxic
effects of NMDA on rat striatal cholinergic neurons.
Neurosci Lett1992; 144:
49–52.
67.
AkaneyaYTakahashiMHatanakaH.
Interleukin-1 beta enhances survival and interleukin-6
protects against MPP+ neurotoxicity in cultures of fetal rat
dopaminergic neurons. Exp Neurol1995; 136:
44–52.
68.
IkedaKKinoshitaMTagayaNCoadministration of interleukin-6 (IL-6) and soluble IL-6
receptor delays progression of wobbler mouse motor neuron
disease. Brain Res1996; 726:
91–7.
69.
GravelCGotzRLorrainASendtnerM.
Adenoviral gene transfer of ciliary neurotrophic factor and
brain-derived neurotrophic factor leads to long-term survival of axotomized
motor neurons. Nat Med1997; 3:
765–70.
70.
YoshidaKTagaTSaitoMTargeted disruption of gp130, a common signal transducer for the
interleukin 6 family of cytokines, leads to myocardial and hematological
disorders. Proc Natl Acad Sci U S A1996; 93:
407–11.
71.
NakashimaKWieseSYanagisawaMDevelopmental requirement of gp130 signaling in neuronal survival
and astrocyte differentiation. J Neurosci1999; 19:
5429–34.
72.
BannerLRPattersonPH.
Major changes in the expression of the mRNAs for cholinergic
differentiation factor/leukemia inhibitory factor and its receptor after
injury to adult peripheral nerves and ganglia. Proc
Natl Acad Sci U S A1994; 91:
7109–13.
73.
HirotaHKiyamaHKishimotoTTagaT.
Accelerated nerve regeneration in mice by upregulated
expression of interleukin (IL) 6 and IL-6 receptor after trauma [see
comments]. J Exp Med1996; 183:
2627–34.
74.
CurtisRSchererSSSomogyiRRetrograde axonal transport of LIF is increased by peripheral
nerve injury: Correlation with increased LIF expression in distal
nerve. Neuron1994; 12:
191–204.
75.
YeJHHouleJD.
Treatment of the chronically injured spinal cord with
neurotrophic factors can promote axonal regeneration from supraspinal
neurons. Exp Neurol1997; 143:
70–81.
76.
BregmanBSMcAteeMDaiHNKuhnPL.
Neurotrophic factors increase axonal growth after spinal cord
injury and transplantation in the adult rat. Exp
Neurol1997; 148:
475–94.
77.
BleschAUyHSGrillRJLeukemia inhibitory factor augments neurotrophin expression and
corticospinal axon growth after adult CNS injury. J
Neurosci1999; 19:
3556–66.
78.
CampbellIL.
Structural and functional impact of the transgenic expression
of cytokines in the CNS. Ann N Y Acad Sci1998; 840:
83–96.
79.
LinLFDohertyDHLileJDGDNF: A glial cell line-derived neurotrophic factor for midbrain
dopaminergic neurons [see comments].
Science1993; 260:
1130–2.
80.
HendersonCEPhillipsHSPollockRAGDNF: A potent survival factor for motoneurons present in
peripheral nerve and muscle [see comments] [published
erratum appears in Science 1995; 267:
777]. Science1994; 266:
1062–4.
81.
KrieglsteinKSuter-CrazzolaraCFischerWHUnsickerK.
TGF-beta superfamily members promote survival of midbrain
dopaminergic neurons and protect them against MPP+
toxicity. EMBO J1995; 14:
736–42.
82.
OppenheimRWHouenouLJJohnsonJEDeveloping motor neurons rescued from programmed and
axotomy-induced cell death by GDNF [see comments].
Nature1995; 373:
344–6.
83.
YanQMathesonCLopezOT.
In vivo neurotrophic effects of GDNF on neonatal and adult
facial motor neurons [see comments]. Nature1995; 373:
341–4.
84.
HottingerAFAzzouzMDeglonNComplete and long-term rescue of lesioned adult motoneurons by
lentiviral-mediated expression of glial cell line-derived neurotrophic
factor in the facial nucleus. J Neurosci2000; 20:
5587–93.
85.
BleschADiergardtNTuszynskiMH.
Cellularly delivered GDNF has robust chemotropic effects in
the non-injured and injured adult rat spinal cord.
Soc Neurosci Abstr1998; 24: 555.
ChengHCaoYOlsonL.
Spinal cord repair in adult paraplegic rats: Partial
restoration of hind limb function [see comments].
Science1996; 273:
510–3.
88.
TengYDMocchettiIWrathallJR.
Basic and acidic fibroblast growth factors protect spinal
motor neurones in vivo after experimental spinal cord
injury. Eur J Neurosci1998; 10:
798–802.
89.
LeeTTGreenBADietrichWDYezierskiRP.
Neuroprotective effects of basic fibroblast growth factor
following spinal cord contusion injury in the rat. J
Neurotrauma1999; 16:
347–56.
90.
OudegaMXuXMGuenardVA combination of insulin-like growth factor-I and
platelet-derived growth factor enhances myelination but diminishes axonal
regeneration into Schwann cell grafts in the adult rat spinal
cord. Glia1997; 19:
247–58.
91.
YePCarsonJD'ErcoleAJ.
In vivo actions of insulin-like growth factor-I (IGF-I) on
brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1)
transgenic mice. J Neurosci1995; 15:
7344–56.
92.
TuszynskiMHWeidnerNMcCormackMGrafts of genetically modified Schwann cells to the spinal cord:
Survival, axon growth, and myelination. Cell
Transplant1998; 7:
187–96.
93.
WeidnerNBleschAGrillRJTuszynskiMH.
Nerve growth factor-hypersecreting Schwann cell grafts
augment and guide spinal cord axonal growth and remyelinate central nervous
system axons in a phenotypically appropriate manner that correlates with
expression of L1. J Comp Neurol1999; 413:
495–506.
94.
Ramon-CuetoAAvilaJ.
Olfactory ensheathing glia: Properties and
function. Brain Res Bull1998; 46:
175–87.
95.
Ramon-CuetoACorderoMISantos-BenitoFFAvilaJ.
Functional recovery of paraplegic rats and motor axon
regeneration in their spinal cords by olfactory ensheathing
glia. Neuron2000; 25:
425–35.
96.
Alvarez-BuyllaALoisC.
Neuronal stem cells in the brain of adult
vertebrates. Stem Cells1995; 13:
263–72.
97.
GageFHCoatesPWPalmerTDSurvival and differentiation of adult neuronal progenitor cells
transplanted to the adult brain. Proc Natl Acad Sci
U S A1995; 92:
11879–83.
98.
WeissSReynoldsBAVescoviALIs there a neural stem cell in the mammalian forebrain?
[see comments]. Trends Neurosci1996; 19:
387–93.
99.
Martinez-SerranoABjorklundA.
Immortalized neural progenitor cells for CNS gene transfer
and repair. Trends Neurosci1997; 20:
530–8.
100.
HeumannRKorschingSBandtlowCThoenenH.
Changes of nerve growth factor synthesis in nonneuronal cells
in response to sciatic nerve transection. J Cell
Biol1987; 104:
1623–31.
101.
AchesonABarkerPAAldersonRFDetection of brain-derived neurotrophic factor-like activity in
fibroblasts and Schwann cells: Inhibition by antibodies to
NGF. Neuron1991; 7:
265–75.
102.
FriedmanBSchererSSRudgeJSRegulation of ciliary neurotrophic factor expression in
myelin-related Schwann cells in vivo.
Neuron1992; 9:
295–305.
103.
MeyerMMatsuokaIWetmoreCEnhanced synthesis of brain-derived neurotrophic factor in the
lesioned peripheral nerve: Different mechanisms are responsible for the
regulation of BDNF and NGF mRNA. J Cell
Biol1992; 119:
45–54.
BungeMB.
Schwann cells regulation of extracellular matrix biosynthesis
and assembly. In: DyckPJThomasPK,
eds. Peripheral neuropathy.
Philadelphia: WB
Saunders, 1993:
299–316.
106.
SeilheimerBSchachnerM.
Regulation of neural cell adhesion molecule expression on
cultured mouse Schwann cells by nerve growth factor.
EMBO J1987; 6:
1611–6.
107.
BixbyJLLilienJReichardtLF.
Identification of the major proteins that promote neuronal
process outgrowth on Schwann cells in vitro. J Cell
Biol1988; 107:
353–61.
108.
GriffinJWHoffmanPN.
Degeneration and regeneration in the peripheral nervous
system. In: DyckPJThomasPK,
eds. Peripheral neuropathy.
Philadelphia: WB
Saunders, 1993:
361–76.
109.
BrookGALawrenceJMShahBRaismanG.
Extrusion transplantation of Schwann cells into the adult rat
thalamus induces directional host axon growth. Exp
Neurol1994; 126:
31–43.
110.
RichardsonPMMcGuinnessUMAguayoAJ.
Axons from CNS neurons regenerate into PNS
grafts. Nature1980; 284:
264–5.
111.
BungeMB.
Transplantation of purified populations of Schwann cells into
lesioned adult rat spinal cord. J Neurol1994; 242:
S36–9.
112.
LiYRaismanG.
Schwann cells induce sprouting in motor and sensory axons in
the adult rat spinal cord. J Neurosci1994; 14:
4050–63.
113.
XuXMGuenardVKleitmanNBungeMB.
Axonal regeneration into Schwann cell-seeded guidance
channels grafted into transected adult rat spinal cord.
J Comp Neurol1995; 351:
145–60.
114.
HonmouOFeltsPAWaxmanSGKocsisJD.
Restoration of normal conduction properties in demyelinated
spinal cord axons in the adult rat by transplantation of exogenous Schwann
cells. J Neurosci1996; 16:
3199–208.
115.
XuXMChenAGuenardVBridging Schwann cell transplants promote axonal regeneration
from both the rostral and caudal stumps of transected adult rat spinal
cord. J Neurocytol1997; 26:
1–16.
116.
XuXMZhangSXLiHRegrowth of axons into the distal spinal cord through a
Schwann-cell-seeded mini-channel implanted into hemisected adult rat spinal
cord. Eur J Neurosci1999; 11:
1723–40.
117.
LeviAD.
Characterization of the technique involved in isolating
Schwann cells from adult human peripheral nerve. J
Neurosci Methods1996; 68:
21–6.
118.
CasellaGTBungeRPWoodPM.
Improved method for harvesting human Schwann cells from
mature peripheral nerve and expansion in vitro.
Glia1996; 17:
327–38.
119.
CasellaGTWieserRBungeRPDensity dependent regulation of human Schwann cell
proliferation. Glia2000; 30:
165–77.
120.
GraziadeiPPGraziadeiMonti
GA. Neurogenesis and
neuron regeneration in the olfactory system of mammals. III. Deafferentation
and reinnervation of the olfactory bulb following section of the fila
olfactoria in rat. J Neurocytol1980; 9:
145–62.
121.
DoucetteJRKiernanJAFlumcrfeltBA.
The re-innervation of olfactory glomeruli following
transection of primary olfactory axons in the central or peripheral nervous
system. J Anat1983; 137:
1–19.
122.
GraziadeiPPGraziadeiMonti
GA. Neuronal changes in
the forebrain of mice following penetration by regenerating olfactory
axons. J Comp Neurol1986; 247:
344–56.
123.
CancalonPF.
Survival and subsequent regeneration of olfactory neurons
after a distal axonal lesion. J Neurocytol1987; 16:
829–41.
124.
GongQBaileyMSPixleySKLocalization and regulation of low affinity nerve growth factor
receptor expression in the rat olfactory system during development and
regeneration. J Comp Neurol1994; 344:
336–48.
125.
RaismanG.
Specialized neuroglial arrangement may explain the capacity
of vomeronasal axons to reinnervate central neurons.
Neuroscience1985; 14:
237–54.
126.
ValverdeFLopez-MascaraqueL.
Neuroglial arrangements in the olfactory glomeruli of the
hedgehog. J Comp Neurol1991; 307:
658–74.
127.
Ramon-CuetoAValverdeF.
Olfactory bulb ensheathing glia: A unique cell type with
axonal growth-promoting properties. Glia1995; 14:
163–73.
128.
PasterkampRJDe WinterFGigerRJVerhaagenJ.
Role for semaphorin III and its receptor neuropilin-1 in
neuronal regeneration and scar formation?Prog Brain Res1998; 117:
151–70.
129.
Ramon-CuetoANieto-SampedroM.
Regeneration into the spinal cord of transected dorsal root
axons is promoted by ensheathing glia transplants.
Exp Neurol1994; 127:
232–44.
130.
NavarroXValeroAGudinoGEnsheathing glia transplants promote dorsal root regeneration and
spinal reflex restitution after multiple lumbar rhizotomy.
Ann Neurol1999; 45:
207–15.
131.
LiYFieldPMRaismanG.
Repair of adult rat corticospinal tract by transplants of
olfactory ensheathing cells [see comments].
Science1997; 277:
2000–2.
132.
LiYFieldPMRaismanG.
Regeneration of adult rat corticospinal axons induced by
transplanted olfactory ensheathing cells. J
Neurosci1998; 18:
10514–24.
133.
GageFHRayJFisherLJ.
Isolation, characterization, and use of stem cells from the
CNS. Annu Rev Neurosci1995; 18:
159–92.
134.
SuhonenJOPetersonDARayJGageFH.
Differentiation of adult hippocampus-derived progenitors into
olfactory neurons in vivo. Nature1996; 383:
624–7.
135.
McDonaldJWLiuXZQuYTransplanted embryonic stem cells survive, differentiate and
promote recovery in injured rat spinal cord. Nat
Med1999; 5:
1410–2.
136.
LiuSQuYStewartTJEmbryonic stem cells differentiate into oligodendrocytes and
myelinate in culture and after spinal cord transplantation.
Proc Natl Acad Sci U S A2000; 97:
6126–31.
137.
AziziSAStokesDAugelliBJEngraftment and migration of human bone marrow stromal cells
implanted in the brains of albino rats—similarities to astrocyte
grafts. Proc Natl Acad Sci U S A1998; 95:
3908–13.
138.
KopenGCProckopDJPhinneyDG.
Marrow stromal cells migrate throughout forebrain and
cerebellum, and they differentiate into astrocytes after injection into
neonatal mouse brains. Proc Natl Acad Sci U S
A1999; 96:
10711–6.
139.
WoodburyDSchwarzEJProckopDJBlackIB.
Adult rat and human bone marrow stromal cells differentiate
into neurons. J Neurosci Res2000; 61:
364–70.
